The seminars bring together Finnish researchers who are active in COVID-19 research and the general audience who are interested in COVID-19 related research. Check all the dates and keynote speakers on this site.
Welcome to the series of COVID-19 related research seminars at the University of Helsinki!
COVID-19 seminars will be organized once in a month. The seminars will feature keynote talks. The events are in English.
The seminars will be supported by the Faculty of Medicine and hosted by Professor Olli Vapalahti with co-hosts, Associate Professor Tarja Sironen and Postdoctoral Researcher Ravi Kant. Due to the current ongoing pandemic and recommendations by University of Helsinki, the seminars will be held in remote mode via Zoom.
Zoom-link for seminars: https://helsinki.zoom.us/j/65882013425?pwd=a2dBY1V5YjkrcTVDUTQwL3JFQ1pDZz09
Meeting ID: 658 8201 3425
Passcode: 123456
Upcoming seminars:
24.5. at 12
Research on SARS-CoV-2 and other emerging viruses at the Zoonosis Science Center (ZSC), Uppsala University, Sweden
Åke Lundkvist, Professor, Uppsala University, Sweden
Past seminars:
19.4.
SARS-CoV-2: from genotype to phenotype
Dr. Bart Haagmans, Principal Investigator, Erasmus MC, The Netherlands
22.3.2022
Using sequences and phylodynamic models to understand SARS-CoV-2 introductions and spread
Dr Samantha Lycett, Infection & Immunity Division, Roslin Institute, University of Edinburgh
15.2.2022
COVID-19 - the pathologists perspective
Jonas Kantonen, PhD Researcher, University of Helsinki, Pathologist, HUS
Spatiotemporal clustering patterns and sociodemographic determinants of COVID-19 (SARS-CoV-2) infections in Helsinki, Finland
Mika Siljander, University Researcher, University of Helsinki
25.1.2022
Intranasal clinical candidate drug combination for SARS-CoV-2: Inhibiting cells to stop the virus
Giuseppe Balistreri, Academy Research Fellow, University of Helsinki
An intranasally administered cross-neutralizing SH3 domain-derived antibody-mimetic efficiently blocks infection by SARS-CoV-2 and its emerging variants of concern
Anna Mäkelä, Senior Scientist, University of Helsinki
7.12.2021
SARS-CoV-2 - a Global One Health Challenge
Tarja Sironen, Associate Professor, University of Helsinki
T cells in the severe COVID-19 - the heros or the villains?
Eliisa Kekäläinen, Docent, University of Helsinki
9.11.2021
Covid-19 vaccinations in children and adolescents
Mika Rämet, Professor, Director of Vaccine Research Center, Tampere University
Introduction, evolution, and circulation of SARS-CoV-2 in Finland
Teemu Smura, Postdoctoral researcher, University of Helsinki
5.10.2021
SARS-CoV-2 immune responses and transmission
Jonas Klingström, Professor, Karolinska Institutet
A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
Esther Gan, Postdoctoral Research Fellow, Duke-NUS Medical School, Singapore
7.9.2021
Development of SARS-CoV-2 clinical laboratory diagnostics
Satu Kurkela, Chief Physician, HUS Diagnostic Center
SARS-CoV-2 variants and vaccine-induced immunity
Laura Kakkola, Docent, University of Turku
26.5.2021
Of mice and men? Sure, but don't forget the hamster...
A pathologist's view of some animal models for COVID-19
Anja Kipar, Professor, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich
COVID modelling: examples of tasks in THL
Simopekka Vänskä, Docent, University of Helsinki, Senior Researcher, Finnish Institute for Health and Welfare
13.4.2021
What do we know about the impact of covid-19 vaccines?
Hanna Nohynek, Chief Physician, Unit: Infectious Diseases Control and Vaccines, Finnish Institute for Health and Welfare
COVID-19 and convalescent plasma: what have we learnt so far?
Heli J. Harvala, Medical Virology Consultant, NHS Blood and Transplant, Adjunct Professor in Molecular Virology, University of Turku
23.3.2021
Engineered antibodies to combat COVID-19
Ilona Rissanen, Postdoctoral Researcher, University of Helsinki
Substrate-selective protein secretion inhibition as a disease-agnostic strategy also against Covid-19
Ville Paavilainen, Docent, Group Leader, University of Helsinki
16.2.2021
The COVID-19 host genetics initiative: a global effort to identify genetic factors of COVID-19 susceptibility, severity, and outcomes across > 200 studies worldwide
Andrea Ganna, EMBL-group leader at FIMM, University of Helsinki
Coagulation and inflammation - implications in COVID-19
Riitta Lassila, Professor in Coagulation Medicine, University of Helsinki
19.1.2021
COVID-19 immunity
Ilkka Julkunen, Professor, Institute of Biomedicine, University of Turku
Wastewater-based surveillance of SARS-CoV-2
Tarja Pitkänen, Associate Professor (environmental health), University of Helsinki, Chief Specialist, Finnish Institute for Health and Welfare
8.12.2020
Adenovectored COVID-19 vaccine
Kalle Saksela, Professor, University of Helsinki
Hijacking the host cell molecular highways
Markku Varjosalo, Research Director, University of Helsinki
Research group: Molecular Systems Biology
10.11.2020
Antibodies against SARS-CoV-2 - are they there and for how long?
Jussi Hepojoki, Academy Research Fellow, University of Helsinki
Research group: Viral Zoonooses Research Unit
Airborne transmission of viruses: aerosol dispersion in public places by fast assessment
Ville Vuorinen, Assistant Professor, Aalto University
6.10.2020
The dogs' nose knows SARS-CoV-2
Anna Hielm-Björkman, Adjunct Professor, University of Helsinki
Research group: DogRisk
Low-density neutrophils in COVID-19
Tomas Strandin, Academy Research Fellow, University of Helsinki
Research group: Viral Zoonooses Research Unit
7.9.2020
Watch the recording in Unitube
Open Sesame: how SARS-CoV-2 enters and spreads in human cells
Giuseppe Balistreri, Academy Research Fellow, University of Helsinki
Research group: Viral Cell Biology
Genetic diversity of SARS-CoV-2
Teemu Smura, Senior Scientist, University of Helsinki
Research group: Viral Zoonooses Research Unit
